European Biotech Acquisition Corp.

General Information

We intend to capitalize on the ability of our management team to identify promising opportunities in the life sciences industry in Europe. (Blank check company incorporated in the Cayman Islands)

(Note: European Biotech Acquisition priced its SPAC IPO on March 15, 2021, in sync with the terms in its prospectus: 10 million units at $10 each to raise $100 million.)

Employees: 0
Founded: 2021
Contact Information
Address Johannes Vermeerplein 9 1071 DV Amsterdam, Netherlands
Phone Number 31 (0) 20 664 55 00
Web Address
View Prospectus: European Biotech Acquisition Corp.
Financial Information
Market Cap $129.0mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol EBACU
Exchange NASDAQ
Shares (millions): 10.0
Price range $10.00 - $10.00
Est. $ Volume $100.0 mil
Manager / Joint Managers Credit Suisse/Kempen & Co.
CO-Managers -
Expected To Trade: 3/16/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change